Concepedia

David Fernández

DF

Statistics

Publications

15

Citations

1.7K

H-Index

13

Active since

2004

Affiliations

State University of New York(Current)

SUNY Upstate Medical University

Georgetown University

Georgetown University Medical Center

Hospital for Special Surgery

David Fernández is an author at State University of New York specializing in life sciences, immunology, and immunopathology.

ORCID

Publications per year

2004–2023

15

Publications

15

Rapamycin reduces disease activity and normalizes T cell activation–induced calcium fluxing in patients with systemic lupus erythematosus

David Fernández, Eduardo Bonilla, Brian Niland et al. · Arthritis & Rheumatism · 2006 · 318 citations

, , +17

Activation of Mammalian Target of Rapamycin Controls the Loss of TCRζ in Lupus T Cells through HRES-1/Rab4-Regulated Lysosomal Degradation

David Fernández, Tiffany Telarico, Eduardo Bonilla et al. · The Journal of Immunology · 2009 · 256 citations · Full text

, , +17

Plasmacytoid dendritic cells promote systemic sclerosis with a key role for TLR8

Marie Dominique Ah Kioon, Claudio Tripodo, David Fernández et al. · Science Translational Medicine · 2018 · 244 citations · Full text

, , +17

HRES-1/Rab4-mediated depletion of Drp1 impairs mitochondrial homeostasis and represents a target for treatment in SLE

Tiffany Caza, David Fernández, Gergely Talabér et al. · Annals of the Rheumatic Diseases · 2013 · 187 citations · Full text

, , +6

Interferon regulatory factor-1 (IRF-1) exhibits tumor suppressor activities in breast cancer associated with caspase activation and induction of apoptosis

Kerrie B. Bouker, Todd C. Skaar, Rebecca B. Riggins et al. · Carcinogenesis · 2005 · 135 citations · Full text

, , +17

1–5 of 15